{
    "meta": {
        "name": "rms_v2.0",
        "timestamp": "20250124",
        "sheet_id": "1hDLvT3O_VfsMuWNR2sWWlIWTyzY8sopYY4e7z5Z1wmQ"
    },
    "info": {
        "title": "Rhabdomyosarcoma (RMS) Data Dictionary",
        "name": "rms_v2.0",
        "release_notes": "",
        "parent_data_model": "pcdc_v2.0",
        "license": "Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/)",
        "wiki": "https://docs.pedscommons.org/",
        "consortium_info": "https://commons.cri.uchicago.edu/pcdc/",
        "description": "The RMS data dictionary is a consensus data schema built by an international group of pediatric rhabdomyosarcoma experts and maintained by Data for the Common Good (D4CG) at the University of Chicago in collaboration with the International Soft Tissue Sarcoma Consortium (INSTRuCT). It is based on the collective requirements of its contributors.",
        "total": 79
    },
    "domains": {
        "protocol": {
            "subject_characteristics": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "Subject identifier assigned by the honest broker.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "CONSORTIUM": {
                    "type": "Enum",
                    "tier": "To-do",
                    "description": "The consortium under which this data is being contributed to the Pediatric Cancer Data Commons.",
                    "codes": [
                        "ncit:C61538"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "INSTRuCT": {
                            "description": "International Pediatric Acute Myeloid Leukemia Consortium (INTERACT). A consortium launched in 2021 as a collaboration between acute myeloid leukemia researchers from Children's Oncology Group, European Pediatric Acute Leukemia, Japan Children's Cancer Group, and St. Jude Children's Research Hospital. To date, INTERACT has identified 18 studies from 10 clinical trials research groups that can be contributed to the data commons, and its statisticians are actively working to harmonize clinical data from more than 6,000 individuals who have had pediatric cancer.",
                            "codes": [
                                "ncit:C192762"
                            ],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        }
                    }
                },
                "DISEASE_GROUP": {
                    "type": "Enum",
                    "tier": "",
                    "description": "",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "RMS": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        }
                    }
                },
                "DATA_CONTRIBUTOR_ID": {
                    "type": "Enum",
                    "tier": "",
                    "description": "An identifier assigned to a data contributor.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "COG": {
                            "description": "Children's Oncology Group. An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.",
                            "codes": [
                                "ncit:C39353"
                            ],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "EpSSG": {
                            "description": "European Paediatric Soft Tissue Sarcoma Study Group. An international organization of healthcare professionals devoted to the care and treatment of children and young people with soft tissue sarcoma.",
                            "codes": [
                                "ncit:C192774"
                            ],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS": {
                            "description": "Cooperative Weichteilsarkom Studiengruppe. An international pediatric soft tissue sarcoma study group, also known as the Cooperative Soft Tissue Sarcoma Group, that creates guidance for risk-adapted treatment of soft tissue sarcoma and soft tissue tumors in children, adolescents, and young adults in Europe.",
                            "codes": [
                                "ncit:C192777"
                            ],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "MMT": {
                            "description": "International Society of Paediatric Oncology Malignant Mesenchymal Tumour Committee. An international pediatric oncology committee that specializes in the research of malignant mesenchymal tumors. Along with the Associazione Italiana Ematologia Oncologia Pediatrica-Soft Tissue Sarcoma Committee (AIEOP-STSC), which was formerly known as the Italian Cooperative Group (ICG), SIOP-MMT founded the European pediatric Soft tissue sarcoma Study Group (EpSSG) and the Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) study in 2005 with the goal of making pediatric non-rhabdomyosarcoma soft tissue sarcoma treatment uniform across Europe.",
                            "codes": [
                                "ncit:C192775"
                            ],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "STSC": {
                            "description": "AIEOP Soft Tissue Sarcoma Committee",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        }
                    }
                },
                "STUDY_ID": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A sequence of characters used to identify, name, or characterize the study.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "ARST0331": {
                            "description": "Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients With Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma. This non-randomized phase III trial is studying how well combination chemotherapy and radiation therapy work in treating patients with newly diagnosed low-risk rhabdomyosarcoma. (ClinicalTrials.gov Identifier: NCT00075582)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST0431": {
                            "description": "Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma. This phase III trial is studying how well giving high-dose combination chemotherapy together with radiation therapy works in treating patients with newly diagnosed metastatic rhabdomyosarcoma or ectomesenchymoma. (ClinicalTrials.gov Identifier: NCT00354744)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST0531": {
                            "description": "Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS). This randomized phase III trial is studying two different combination chemotherapy regimens to compare how well they work when given together with radiation therapy in treating patients with newly diagnosed rhabdomyosarcoma. (ClinicalTrials.gov Identifier: NCT00354835)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST08P1": {
                            "description": "A Pilot Study to Evaluate Novel Agents (Temozolomide and Cixutumumab [IMC-A12, Anti-IGF-IR Monoclonal Antibody NSC # 742460]) in Combination With Intensive Multi-agent Interval Compressed Therapy for Patients With High-Risk Rhabdomyosarcoma. This randomized pilot clinical trial is studying the side effects and how well giving temozolomide and cixutumumab together with combination chemotherapy works in treating patients with metastatic rhabdomyosarcoma. (ClinicalTrials.gov Identifier: NCT01055314)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9602": {
                            "description": "Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. The objective of this study is to decrease toxicity in similar patients by reducing radiotherapy (RT) doses and eliminating cyclophosphamide for the lowest-risk patients. (Raney RB, Walterhouse DO, Meza JL, et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol. 2011;29(10):1312-1318. doi:10.1200/JCO.2010.30.4469)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9802": {
                            "description": "Rhabdomyosarcoma: Review of the Children\u2019s Oncology Group (COG) Soft-Tissue Sarcoma Committee Experience and Rationale for Current COG Studies. (Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59(1):5-10. doi:10.1002/pbc.24118)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9803": {
                            "description": "Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803. The purpose of this randomized study was to compare the outcome of patients with intermediate-risk rhabdomyosarcoma (RMS) treated with standard VAC (vincristine, dactinomycin, and cyclophosphamide) chemotherapy to that of patients treated with VAC alternating with vincristine, topotecan, and cyclophosphamide (VAC/VTC). (DOI: 10.1200/JCO.2009.22.3768 Journal of Clinical Oncology 27, no. 31 (November 01, 2009) 5182-5188.)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "RMS2005": {
                            "description": "A Protocol For Nonmetastatic Rhabdomyosarcoma [RMS-2005]. This randomized phase III trial is studying different combination chemotherapy regimens to compare how well they work in treating young patients with nonmetastatic rhabdomyosarcoma. (ClinicalTrials.gov Identifier: NCT00379457)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "MTS2008": {
                            "description": "Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study. This study presents the results of the MTS 2008 study with a pooled analysis including patients from the concurrent BERNIE study. (Schoot RA, Chisholm JC, Casanova M, et al. Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study. J Clin Oncol. 2022;40(32):3730-3740. doi:10.1200/JCO.21.02981)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ICG RMS96": {
                            "description": "Localized vaginal/uterine rhabdomyosarcoma\u2014results of a pooled analysis from four international cooperative groups. The purpose of this study is to explore the impact of radiation therapy on local failure rate and OS when used as part of primary treatment, and to assess the use of intracavitary brachytherapy between the different cooperative groups. (Minard-Colin V, Walterhouse D, Bisogno G, et al. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups. Pediatr Blood Cancer. 2018;65(9):e27096. doi:10.1002/pbc.27096)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "RMS 4.99": {
                            "description": "Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma. The RMS4.99 study was designed to explore the role of multiple sequential high-dose chemotherapy cycles administered early in the treatment of children with metastatic rhabdomyosarcoma. (Bisogno, Gianni & Ferrari, Andrea & Prete, Arcangelo & Messina, Chiara & Basso, Eleonora & Cecchetto, Giovanni & Indolfi, Paolo & Scarzello, Giovanni & D'Angelo, Paolo & De Sio, Luigi & Di Cataldo, Andrea & Carli, Modesto. (2009). Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma. European journal of cancer (Oxford, England : 1990). 45. 3035-41. 10.1016/j.ejca.2009.08.019)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS-IV-2002": {
                            "description": "Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Report prognostic factors and outcome of patients receiving multimodal treatment for RMS followed by either LTMT, HDCT, or alloHSCT. In addition, we compared the prognosis of patients who received either O-TIE or CYC/VBL as LTMT. The treatment decisions are based on the choice of the treating attending physicians. (Tramsen L, Bochennek K, Sparber-Sauer M, et al. Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers (Basel). 2023;15(7):2050. Published 2023 Mar 30. doi:10.3390/cancers15072050)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS2002P": {
                            "description": "Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol.  This trial reports the results of the prospective, non-randomized, historically controlled CWS-2002P study in patients \u2264 21 years with localized RMS developed with the aim to improve the long-term outcome by adapting the burden of therapy to risk profile and to investigate the feasibility and relation to the outcome of maintenance therapy (MT) in the high-risk groups. (Koscielniak E, Blank B, Vokuhl C, et al. Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol. Cancers (Basel). 2022;14(4):899. Published 2022 Feb 11. doi:10.3390/cancers14040899)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS91": {
                            "description": "Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. The purpose of this trial is to improve risk-adapted therapy for localized childhood soft tissue sarcoma within an international multicenter setting. (Dantonello TM, Int-Veen C, Harms D, et al. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol. 2009;27(9):1446-1455. doi:10.1200/JCO.2007.15.0466)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS96": {
                            "description": "Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. This trial studies the efficacy of high dose therapy (HDT) versus an oral maintenance treatment (OMT) in patients with stage IV soft tissue sarcoma (STS). (Klingebiel T, Boos J, Beske F, et al. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer. 2008;50(4):739-745. doi:10.1002/pbc.21494)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "MMT95": {
                            "description": "MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood. This randomized phase III trial is studying surgery followed by different regimens of combination chemotherapy given together with radiation therapy and/or additional surgery to compare how well they work in treating patients with soft tissue sarcoma. (ClinicalTrials.gov Identifier: NCT00002898)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        }
                    }
                },
                "TREATMENT_ARM": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A specific treatment plan within a clinical trial that describes the activities a subject will be involved in as he or she progresses through the study.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "ARST0331:Regimen I": {
                            "description": "Patients received treatment in the following course sequence: 1) VAC chemotherapy comprising vincristine sulfate IV over 1 minute on day 1 of weeks 1-9 and dactinomycin IV over 1 minute and cyclophosphamide IV over 1 hour on day 1 of weeks 1, 4, 7, and 1; 2) VA chemotherapy comprising vincristine sulfate IV over 1 minute on day 1 of weeks 13-21 and dactinomycin IV over 1 minute on day 1 of weeks 13, 16, 19, and 22 (dactinomycin is omitted during radiation therapy); 3) Radiation therapy, 5 days a week, beginning on week 13 and continuing for 4-7 weeks, depending on prescribed dose.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST0331:Regimen II": {
                            "description": "Patients received treatment in the following course sequence: 1) VAC chemotherapy and radiation therapy as in regimen I; 2) VA chemotherapy comprising vincristine sulfate IV over 1 minute on day 1 of weeks 13-21, 25-33, and 37-45 and dactinomycin IV over 1 minute on day 1 of weeks 13, 16, 19, 22, 25, 28, 31, 34, 37, 40, 43, and 46 (dactinomycin is omitted during radiation therapy).",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST0431:High Risk Rhabdomyosarcoma": {
                            "description": "Patients received treatment in the following course sequence: 1) Parameningeal (without intracranial extension) and paraspinal tumors receive chemotherapy starting Week 1 and begin radiation therapy at Week 20; 2) Weeks 1-6: vincristine sulfate and irinotecan hydrochloride; 3) Weeks 7-34: vincristine sulfate and irinotecan hydrochloride, Cyclophosphamide with MESNA, Doxorubicin hydrochloride, Etoposide, Ifosfamide with MESNA; 4) Weeks 35-54: vincristine sulfate, Dactinomycin, irinotecan hydrochloride and Cyclophosphamide with MESNA and Filgrastim; 5) Radiation therapy beginning at Week 20; 6) Second look conventional surgery: Surgical resection other than biopsy will be applicable for the majority of patients.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST0531:Arm I (Chemotherapy, Radiotherapy)": {
                            "description": "Patients randomized with the following course sequence: 1) VAC chemotherapy comprising vincristine IV over 1 minute on day 1 of weeks 1-13, 16, 19-25, 28, 31-37, and 40; 2) Dactinomycin IV over 1-5 minutes on day 1 of weeks 1, 4, 13, 16, 19, 22, 25, 28, 31, 34, 37,and 40; 3) Cyclophosphamide IV over 1 hour on day 1 of weeks 1, 4, 7, 10, 13, 16, 19, 22, 25, 28, 31, 34, 37, and 40; 4) Patients may also undergo radiotherapy 5 days a week for 4-6 weeks beginning in week 4.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST0531:Arm II (Chemotherapy, Radiotherapy)": {
                            "description": "Patients randomized with the following course sequence: 1) VAC chemotherapy alternating with VI chemotherapy comprising vincristine IV over 1 minute on day 1 of weeks 1-13, 16, 17, 19, 20, 22-26, 28, 31-34, 37, 38, and 40; 2) Dactinomycin IV over 1-5 minutes on day 1 of weeks 1, 13, 22, 28, 34, and 40; 3) Cyclophosphamide IV over 1 hour on day 1 of weeks 1,10, 13, 22, 28, 34, and 40; 4) Irinotecan hydrochloride IV over 1 hour on days 1-5 of weeks 4, 7, 16, 19, 25, 31, and 37; 5) Patients may also undergo radiotherapy 5 days a week for 4-6 weeks beginning in week 4.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ARST08P1:Group 1 (Chemotherapy, Radiation Therapy, Cixutumumab)": {
                            "description": "Patients randomized with the following course sequence: 1) Vincristine sulfate IV over 1 minute on day 1 of weeks 1-5, 7, 8, 11, 12, 15, 16, 20-24, 28, 29, 32, 33, 35, 38, 41-44, 47, 48, 50, and 51; 2) Irinotecan hydrochloride IV over 90 minutes on days 1-5 of weeks 1, 4, 20, 23, 47, and 50; 3) Ifosfamide IV over 1 hour and etoposide IV over 1-2 hours on days 1-5 of weeks 9, 13, 17, 26, and 30; 4) Doxorubicin hydrochloride IV over 1-15 minutes on days 1 and 2 of weeks 7, 11, 15, 28, and 32; 5) Cyclophosphamide IV over 30-60 minutes on day 1 of weeks 7, 11, 15, 28, 32, 35, 38, 41, and 44; 6) Dactinomycin IV over 1-5 minutes on day 1 of weeks 35, 38, 41, and 44; 7) Cixutumumab IV over 1 hour on day 1 of weeks 1-51; 8) Patients also undergo radiation therapy on days 1-5 of weeks 20-24.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9602:Subgroup A": {
                            "description": "Patients received treatment in the following course sequence: 1) Vincristine plus dactinomycin (VA).",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9602:Subgroup B": {
                            "description": "Patients received treatment in the following course sequence: 1) Vincristine (VA) plus cyclophosphamide.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9802": {
                            "description": "Patients randomized with the following course sequence: 1) Bevacizumab on day 1 or temsirolimus on days 1, 8, and 15 of each 21-day treatment cycle, together with vinorelbine on days 1 and 8, and cyclophosphamide on day 1 for a maximum of 12 cycles; 2) Local tumor control with surgery and/or radiation therapy was permitted after 6 weeks of treatment.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "D9803": {
                            "description": "Patients randomized with the following course sequence: 1) Bevacizumab on day 1 or temsirolimus on days 1, 8, and 15 of each 21-day treatment cycle, together with vinorelbine on days 1 and 8, and cyclophosphamide on day 1 for a maximum of 12 cycles; 2) Local tumor control with surgery and/or radiation therapy was permitted after 6 weeks of treatment.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "RMS2005": {
                            "description": "Patients randomized with the following course sequence: 1) 9 cycles of IVA +/\u2212 doxorubicin, surgery, and/or radiotherapy.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "MTS2008": {
                            "description": "Patients received treatment in the following course sequence: 1) Four cycles of ifosfamide, vincristine, and actinomycin D (IVA) plus doxorubicin, five cycles of IVA, and 12 cycles of maintenance chemotherapy (low-dose cyclophosphamide and vinorelbine).",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "ICG RMS96": {
                            "description": "Patients received treatment in the following course sequence: 1) Radiation therapy (RT) ",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "RMS 4.99": {
                            "description": "Patients received treatment in the following course sequence: 1) Three cycles of initial standard chemotherapy; 2) One course of cyclophosphamide and etoposide to obtain peripheral blood stem cells (PBSC); 3) Three consecutive high-dose combinations followed by PBSC rescue; 4) Surgery and/or radiotherapy, after which a final maintenance treatment with six courses of vincristine, actinomycin D and cyclophosp.hamide was administered",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS-IV-2002": {
                            "description": "Patients received treatment in the following course sequence: 1) Two courses of topotecan and carboplatin; 2) Two consecutive cycles of ifosfamide, vincristine, actinomycin D (I3VA), ifosfamide, vincristine, adriamycin (I3VAd), and TC",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS2002P:LR": {
                            "description": "Patients received treatment in the following course sequence: 1) Vincristine (VCR), dactinomycin (ACTO-D)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS2002P:SR": {
                            "description": "Patients received treatment in the following course sequence: 1) Vincristine (VCR), dactinomycin (ACTO-D) and ifosfamide (IFO)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS2002P:HR": {
                            "description": "Patients received treatment in the following course sequence: 1) Vincristine (VCR), dactinomycin (ACTO-D), ifosfamide (IFO) and doxorubicin; 2) Low-dose cyclophosphamide and vinblastine maintenance therapy (MT) over 6 months.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS2002P:VHR": {
                            "description": "Patients received treatment in the following course sequence: 1) Vincristine (VCR), dactinomycin (ACTO-D), ifosfamide (IFO) and doxorubicin; 2) Low-dose cyclophosphamide and vinblastine maintenance therapy (MT) over 6 months.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS91": {
                            "description": "Patients received treatment in the following course sequence: 1) Etoposide, vincristine, dactinomycin, ifosfamide, and doxorubicin (EVAIA)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS96:High Dose Therapy (HDT)": {
                            "description": "Patients received treatment in the following course sequence: 1) Carboplatin, etoposide, vincristine, actinomycin D, ifosfamide, and epirubicin; 2) Cycle of thiotepa (600 mg/m2) plus cyclophosphamide (4,500 mg/m2) and melphalan (120 mg/m2) plus etoposide (1,800 mg/m2)",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "CWS96:Oral Maintenance Therapy (OMT)": {
                            "description": "Patients received treatment in the following course sequence: 1) Carboplatin, etoposide, vincristine, actinomycin D, ifosfamide, and epirubicin; 2) Four cycles trofosfamide (10 days 2\u2009\u00d7\u200975 mg/m2/day) plus etoposide (10 days 2\u2009\u00d7\u200925 mg/m2/day), and 4 cycles trofosfamide (10 days 2\u2009\u00d7\u200975 mg/m2/day) plus idarubicin (10 days 4\u2009\u00d7\u20095 mg/m2).",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        },
                        "MMT95": {
                            "description": "Patients randomized with the following course sequence: 1) Ifosfamide, vincristine, and dactinomycin (IVA) or a six-drug combination (IVA plus carboplatin, epirubicin, and etoposide) both delivered over 27 weeks.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "New PD"
                            ]
                        }
                    }
                },
                "CENSOR_STATUS": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Censor Status",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Subject is censored (i.e. has had no events(s)": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Subject has had one or more events": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            },
            "time_period": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "SUBMITTER_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "An ID provided by the data contributor that identifies a unique time period and that is referenced throughout subsequent tabels in the TIME_PERIOD_SUBMITTER_ID variables.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "PARENT_SUBMITTER_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The SUBMITTER_ID of the time period in whose context a subsequent time period takes place. For example, multiple treatment courses occuring the \"Initial Diagnosis\" period would each reference the SUBMITTER_ID of the \"Initial Diagnosis\" period as their PARENT_SUBMITTER_ID.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "TIME_PERIOD_TYPE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The type of time period being reported.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "Disease Phase": {
                            "description": "The stage or period of an individual's disease.",
                            "codes": [
                                "ncit:C168878"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Course": {
                            "description": "The type of protocol treatment course administered with respect to Course Timing.",
                            "codes": [
                                "ncit:C187095"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "DISEASE_PHASE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The phase of the cancer treatment process during which relevant observations were recorded. This variable is used across domains to frame the timing of these longitudinal observations and reduce the number of redundant variables needed to report similar concepts (see \"Disease Phase Timing and Course Table\" in the documentation for additional guidance).",
                    "codes": [
                        "ncit:C168878"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Disease Phase Timing].[DISEASE_PHASE] skos:exactMatch [rms_v2.0].[Time Period].[DISEASE_PHASE]"
                    ],
                    "permissible_values": {
                        "Initial Diagnosis": {
                            "description": "The first diagnosis of the individual's condition.",
                            "codes": [
                                "ncit:C156813"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Relapse": {
                            "description": "The return of a disease after a period of remission.",
                            "codes": [
                                "ncit:C38155"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Progression": {
                            "description": "A process that manifests as the worsening of a disease over time.",
                            "codes": [
                                "ncit:C17747"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "COURSE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The protocol treatment \"course\" during which relevant observations were recorded. This variable is used across domains to frame the timing of these longitudinal observations and reduce the number of redundant variables needed to report similar concepts (see \"Disease Phase Timing and Course Table\" in the documentation for additional guidance).",
                    "codes": [
                        "ncit:C168807"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Course Timing].[COURSE] skos:exactMatch [rms_v2.0].[Time Period].[COURSE]"
                    ],
                    "permissible_values": {
                        "Prephase": {
                            "description": "A chemotherapy treatment administered prior to the definitive chemotherapy treatment.",
                            "codes": [
                                "ncit:C168826"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Induction": {
                            "description": "The first choice of treatment for a particular type of cancer.",
                            "codes": [
                                "ncit:C158876"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Intensification": {
                            "description": "A second round of intense chemotherapy as part of consolidation therapy.",
                            "codes": [
                                "ncit:C173105"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Consolidation": {
                            "description": "Treatment that is given after initial therapy to kill any remaining cancer cells.",
                            "codes": [
                                "ncit:C15679"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Maintenance": {
                            "description": "Continuation of treatment for an extended period of time to prevent relapse.",
                            "codes": [
                                "ncit:C15688"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "TIME_PERIOD_NUMBER": {
                    "type": "Integer",
                    "tier": "",
                    "description": "This variable indicates the ordinal numbering of time periods of the same TIME_PERIOD_TYPE within its various subgroups (e.g., Relapse 1, Relapse 2, Relapse 3, etc.). The observations across domains can therefore be organized longitudinally without the need for specific dates.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Disease Phase Timing].[DISEASE_PHASE_NUMBER] skos:broadMatch [rms_v2.0].[Time Period].[TIME_PERIOD_NUMBER] ",
                        " [rms_v1.0].[Course Timing].[COURSE_NUMBER] skos:broadMatch [rms_v2.0].[Time Period].[TIME_PERIOD_NUMBER]"
                    ]
                },
                "YEAR_AT_START": {
                    "type": "Integer",
                    "tier": "",
                    "description": "The year at the start of the indicated time period.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Disease Phase Timing].[YEAR_AT_DISEASE_PHASE] skos:exactMatch [rms_v2.0].[Time Period].[YEAR_AT_START]"
                    ]
                },
                "AGE_AT_START": {
                    "type": "Integer",
                    "tier": "",
                    "description": "The age (in days) of the patient at the start of the reported time period.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Disease Phase Timing].[AGE_AT_DISEASE_PHASE] skos:broadMatch [rms_v2.0].[Time Period].[AGE_AT_START] ",
                        " [rms_v1.0].[Course Timing].[AGE_AT_COURSE_START] skos:broadMatch [rms_v2.0].[Time Period].[AGE_AT_START]"
                    ]
                },
                "AGE_AT_END": {
                    "type": "Integer",
                    "tier": "",
                    "description": "The age (in days) of the patient at the end of the reported time period.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Course Timing].[AGE_AT_COURSE_END] skos:exactMatch [rms_v2.0].[Time Period].[AGE_AT_END]"
                    ]
                }
            }
        },
        "demographics": {
            "demographics": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "SEX": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Male": {
                            "description": "A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both.",
                            "codes": [
                                "C20197"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Female": {
                            "description": "A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both.",
                            "codes": [
                                "C16576"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "RACE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "American Indian or Alaska Native": {
                            "description": "A person having origins in any of the original peoples of North and South America (including Central America) and who maintains tribal affiliation or community attachment. (OMB)",
                            "codes": [
                                "C41259"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Asian": {
                            "description": "A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent, including for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (OMB)",
                            "codes": [
                                "C41260"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Black or African American": {
                            "description": "A person having origins in any of the Black racial groups of Africa. Terms such as \"Haitian\" or \"Negro\" can be used in addition to \"Black or African American\". (OMB)",
                            "codes": [
                                "C16352"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Multiracial": {
                            "description": "Having ancestors of several or various races.",
                            "codes": [
                                "C67109"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Native Hawaiian or Other Pacific Islander": {
                            "description": "A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. (OMB)",
                            "codes": [
                                "C41219"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "White": {
                            "description": "A person having origins in any of the original peoples of Europe, the Middle East, or North Africa. (OMB)",
                            "codes": [
                                "C41261"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other": {
                            "description": "Different than the one(s) previously specified or mentioned.",
                            "codes": [
                                "C17649"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "ETHNICITY": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A social group characterized by a distinctive social and cultural tradition that is maintained from generation to generation. Members share a common history and origin and a sense of identification with the group. They have similar and distinctive features in their lifestyle habits and shared experiences. They often have a common genetic heritage which may be reflected in their experience of health and disease.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Hispanic or Latino": {
                            "description": "A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, \"Spanish origin,\" can be used in addition to \"Hispanic or Latino.\" (OMB)",
                            "codes": [
                                "C17459"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Hispanic or Latino": {
                            "description": "A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race.",
                            "codes": [
                                "C41222"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            },
            "survival_characteristics": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_LKSS": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age in Days at Last Known Survival Status",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "LKSS": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The individual's last known survival status.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Alive": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Dead": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "CAUSE_OF_DEATH": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The circumstance or condition that results in the death of a living being.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Disease Progression": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [
                                "Note: If multiple causes of death, include one observation per cause of death.  However, only one cause of death can have the varaiable CAUSE_OF_DEATH_RANKING=Primary."
                            ],
                            "mappings": []
                        },
                        "Treatment-Related Mortality": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Secondary Malignancy": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "CAUSE_OF_DEATH_OTHER": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Cause of Death Other",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {}
                }
            }
        },
        "testing": {
            "molecular_analysis": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_MOLECULAR_ANALYSIS": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age of subject (in days) when molecular analysis was performed.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "MOLECULAR_ABNORMALITY": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A molecular or cytogenic abnormality which occurs in either human disease states or disease models.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "PAX3-FOXO1": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [
                                "Note: If multiple molecular abnormalities, include one observation per molecular abnormality."
                            ],
                            "mappings": []
                        },
                        "PAX7-FOXO1": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "PAX3-Other": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other-FOXO1": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "VARIANT_TYPE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A variation in or modification of the molecular sequence of a gene or gene product.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Translocation": {
                            "description": "Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.",
                            "codes": [
                                "C25756"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Inversion": {
                            "description": "A structural change in genomic DNA where the 5' to 3' order of a nucleotide sequence is completely reversed to the 3' to 5' order relative to its adjacent sequences. This inversion is termed either pericentric, if it includes the centromere of a chromosome, or pancentric, if it excludes the centromere. An inversion mutation abnormality may be heritable or occur somatically.",
                            "codes": [
                                "C45589"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Mutation": {
                            "description": "Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.",
                            "codes": [
                                "C45576"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Single Nucleotide Variant": {
                            "description": "A variation of a single nucleotide at a specific location of the genome due to base substitution, which is found at any frequency in the population.",
                            "codes": [
                                "C146674"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Copy Integer Alteration": {
                            "description": "Variation in the Integer of copies of a particular sequence within the genetic material of an individual. Large-scale copy Integer polymorphisms are common and widely distributed in the human genome.",
                            "codes": [
                                "C40207"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Rearrangement": {
                            "description": "Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.",
                            "codes": [
                                "C16611"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Deletion": {
                            "description": "Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.",
                            "codes": [
                                "C19296"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Amplification": {
                            "description": "Addition of extra material.",
                            "codes": [
                                "C25418"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other": {
                            "description": "Different than the one(s) previously specified or mentioned.",
                            "codes": [
                                "C17649"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "CHROMOSOME": {
                    "type": "String",
                    "tier": "",
                    "description": "One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "GENE1": {
                    "type": "String",
                    "tier": "",
                    "description": "The gene symbol that represents either a single gene that has a mutation or the gene that comprises the 5' portion of the coding sequence involved in a fusion gene mutation.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "GENE2": {
                    "type": "String",
                    "tier": "",
                    "description": "The gene symbol that represents the gene that comprises the 3' portion of the coding sequence for a fusion gene.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "MOLECULAR_ABNORMALITY_RESULT": {
                    "type": "Enum",
                    "tier": "",
                    "description": "An indicator for whether a molecular analysis procedure was performed and whether the assay detected a molecular abnormality.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Positive": {
                            "description": "A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.",
                            "codes": [
                                "C38758"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Negative": {
                            "description": "A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.",
                            "codes": [
                                "C38757"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Done": {
                            "description": "Indicates a task, process or examination that has either not been initiated or not been completed.",
                            "codes": [
                                "C49484"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "ANAPLASIA": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Anaplasia",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Absent": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Present": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "ANAPLASIA_EXTENT": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Anaplasia Extent",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Diffuse": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Focal": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            }
        },
        "disease_attributes": {
            "diagnosis": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_DIAG_ASSESSMENT": {
                    "type": "Integer",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The age (in days) of the subject at the time of this diagnostic assessment.",
                    "codes": [
                        "ncit:C175004"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Histology].[AGE_AT_HIST_ASSESSMENT] skos:exactMatch [rms_v2.0].[Histology].[AGE_AT_DIAG_ASSESSMENT]"
                    ]
                },
                "DIAGNOSIS_BASIS": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The type of diagnosis used for determining the medical condition.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "Histological": {
                            "description": "Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.",
                            "codes": [
                                "ncit:C25526"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "DIAGNOSIS": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.",
                    "codes": [
                        "ncit:C15220"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Histology].[HISTOLOGY] skos:exactMatch [rms_v2.0].[Histology].[DIAGNOSIS]"
                    ],
                    "permissible_values": {
                        "Alveolar rhabdomyosarcoma (ARMS)": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [
                                "Note: If multiple histological findings, include one observation per histological finding."
                            ],
                            "mappings": []
                        },
                        "Botryoid rhabdomyosarcoma (BRMS)": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Embryonal rhabdomyosarcoma (ERMS)": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Pleomorphic rhabdomyosarcoma (PRMS)": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Rhabdomyosarcoma (RMS), not classifiable": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Rhabdomyosarcoma (RMS), inadequate tissue for classification": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Rhabdomyosarcoma (RMS), with Mixed Embryonal and Alveolar Features": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Spindle cell": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            },
            "staging": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_STAGING": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age of subject (in days) at the time of the staging assessment.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "TNM_FINDING": {
                    "type": "Enum",
                    "tier": "",
                    "description": "TNM Finding",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Favorable Site, M0": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [
                                "Note: Tied to AGE_AT_STAGING."
                            ],
                            "mappings": []
                        },
                        "Other site, any T, a, N0, M0": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other site, any T, a, N1, M0, any T, b, N0/N1, M0": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Metastases, ML": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "GROUP": {
                    "type": "Enum",
                    "tier": "",
                    "description": "IRS Surgical-Pathologic Grouping System",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Staging].[IRS_GROUP] skos:exactMatch [rms_v2.0].[Staging].[GROUP]"
                    ],
                    "permissible_values": {
                        "IRS, Group I": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [
                                "Note: Tied to AGE_AT_STAGING."
                            ],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group I] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group I]"
                            ]
                        },
                        "IRS, Group IIA": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group IIA] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group IIA]"
                            ]
                        },
                        "IRS, Group IIB": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group IIB] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group IIB]"
                            ]
                        },
                        "IRS, Group IIC": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group IIC] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group IIC]"
                            ]
                        },
                        "IRS, Group II NOS": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group II, NOS] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group II NOS]"
                            ]
                        },
                        "IRS, Group III": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group III] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group III]"
                            ]
                        },
                        "IRS, Group IV": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": [
                                "[rms_v1.0].[Staging].[IRS_GROUP].[Group IV] skos:exactMatch [rms_v2.0].[Staging].[GROUP].[IRS, Group IV]"
                            ]
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            },
            "disease_site_assessment": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_DISEASE_SITE_ASSESSMENT": {
                    "type": "Integer",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The age (in days) of the subject at the time of this disease site assessment.",
                    "codes": [
                        "ncit:C174997"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[AGE_AT_TUMOR_ASSESSMENT] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[AGE_AT_DISEASE_SITE_ASSESSMENT]"
                    ]
                },
                "CLASSIFICATION": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The classification of a tumor based primarily on histopathological characteristics.",
                    "codes": [
                        "ncit:C174459"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[TUMOR_CLASSIFICATION] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[CLASSIFICATION]"
                    ],
                    "permissible_values": {
                        "Primary": {
                            "description": "A tumor at the original site of origin.",
                            "codes": [
                                "ncit:C8509"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Regional": {
                            "description": "A disease or condition that extends beyond the site and spreads into adjacent tissues and regional lymph nodes.",
                            "codes": [
                                "ncit:C41844"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Metastatic": {
                            "description": "A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.",
                            "codes": [
                                "ncit:C14174"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "ncit:C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "ncit:C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "SITE": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The anatomical site on which the disease is assessed.",
                    "codes": [
                        "ncit:C166232"
                    ],
                    "implementation_notes": [
                        "Note: If there were multiple primary sites, include one observation per primary site."
                    ],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[TUMOR_SITE] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[SITE]"
                    ],
                    "permissible_values": {
                        "Abdomen": {
                            "description": "The cavity located between the lungs and pelvis. It contains the lower esophagus, stomach, pancreas, intestines, liver, gallbladder and spleen.",
                            "codes": [
                                "ncit:C12664"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Anal/Perianal": {
                            "description": "The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded. | The skin area around the anus.",
                            "codes": [
                                "ncit:C43362",
                                "ncit:C99148"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bladder": {
                            "description": "The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.",
                            "codes": [
                                "ncit:C12414"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bladder/Prostate": {
                            "description": "The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. | The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.",
                            "codes": [
                                "ncit:C12414",
                                "ncit:C12410"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone": {
                            "description": "The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.",
                            "codes": [
                                "ncit:C12366"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone Marrow": {
                            "description": "The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.",
                            "codes": [
                                "ncit:C12431"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Brain": {
                            "description": "An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.",
                            "codes": [
                                "ncit:C12439"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Cervix": {
                            "description": "The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.",
                            "codes": [
                                "ncit:C12311"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Cheek": {
                            "description": "The fleshy part of the face bounded by the eyes, nose, ear, and jaw line.",
                            "codes": [
                                "ncit:C13070"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Distant Lymph Nodes": {
                            "description": "A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.",
                            "codes": [
                                "ncit:C12745"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Eyelid": {
                            "description": "A thin membrane of skin with the purpose of covering and protecting an eye.",
                            "codes": [
                                "ncit:C12713"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Foot": {
                            "description": "The structure found below the ankle joint required for locomotion.",
                            "codes": [
                                "ncit:C32622"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Forearm": {
                            "description": "The structure on the upper limb, between the elbow and the wrist.",
                            "codes": [
                                "ncit:C32628"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Hand": {
                            "description": "The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits.",
                            "codes": [
                                "ncit:C32712"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Hypopharynx": {
                            "description": "The lower part of the pharynx that connects to the esophagus.",
                            "codes": [
                                "ncit:C12246"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Infratemporal Fossa/Pterygopalatine": {
                            "description": "The infratemporal fossa, also known as the pterygopalatine fossa, is a complex anatomical region located in the human skull, specifically on the lateral aspect of the skull base. It is situated deep within the skull, adjacent to the maxillary (upper jaw) and sphenoid bones. This anatomical area is crucial in housing and providing passage for various important structures, including nerves, blood vessels, and muscles.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Kidney": {
                            "description": "One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secrete metabolic products and minerals from the blood, thus maintaining homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.",
                            "codes": [
                                "ncit:C12415"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Knee": {
                            "description": "A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends.",
                            "codes": [
                                "ncit:C32898"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Larynx": {
                            "description": "The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production.",
                            "codes": [
                                "ncit:C12420"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Leg": {
                            "description": "The portion of the lower extremity between the knee and the ankle. For clinical purposes this term is also used to refer to the whole inferior limb.",
                            "codes": [
                                "ncit:C32974"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Liver/Biliary Tract": {
                            "description": "A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate. | The system that transports bile from the hepatocytes in the liver to the small intestine. It is comprised of the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, and the gallbladder.",
                            "codes": [
                                "ncit:C12392",
                                "ncit:C12678"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Lower Leg": {
                            "description": "The lower leg is the portion of the lower limb, also known as the leg, that extends from the knee joint down to the ankle joint. It is located between the upper leg (thigh) and the foot and is an essential anatomical structure that facilitates movement, weight-bearing, and locomotion.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Lung": {
                            "description": "One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.",
                            "codes": [
                                "ncit:C12468"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Middle Ear": {
                            "description": "The part of the ear including the eardrum and ossicles. The middle ear leads to the inner ear.",
                            "codes": [
                                "ncit:C12274"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasal Cavity": {
                            "description": "The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.",
                            "codes": [
                                "ncit:C12424"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasopharynx": {
                            "description": "The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.",
                            "codes": [
                                "ncit:C12423"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Neck": {
                            "description": "The region that connects the head to the rest of the body.",
                            "codes": [
                                "ncit:C13063"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Oral Cavity": {
                            "description": "The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.",
                            "codes": [
                                "ncit:C12421"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Orbit": {
                            "description": "The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.",
                            "codes": [
                                "ncit:C12347"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Oropharynx": {
                            "description": "The part of the pharynx between the soft palate and the upper portion of the epiglottis.",
                            "codes": [
                                "ncit:C12762"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Ovary": {
                            "description": "One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.",
                            "codes": [
                                "ncit:C12404"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paranasal Sinuses": {
                            "description": "Any one of the air-filled spaces within the ethmoid, frontal, maxillary, or sphenoid bones, which communicate with the nasal cavity.",
                            "codes": [
                                "ncit:C12763"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parapharyngeal Area": {
                            "description": "A cone-shaped lateral neck space with its base on the base of the skull and its apex at the hyoid bone.",
                            "codes": [
                                "ncit:C162818"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paraspinal": {
                            "description": "Pertaining to muscles and/or tissue adjacent to the spinal column.",
                            "codes": [
                                "ncit:C129461"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paratesticular": {
                            "description": "A small anatomical compartment that contains the testicular collecting system, and mesothelial and mesenchymal components that represent extensions of the abdominal cavity and retroperitoneum.",
                            "codes": [
                                "ncit:C162491"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parathyroid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parotid": {
                            "description": "The largest of the three paired salivary glands, located in front of the ear.",
                            "codes": [
                                "ncit:C12427"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Pelvis": {
                            "description": "The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.",
                            "codes": [
                                "ncit:C12767"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Perineum": {
                            "description": "The area located between the anus and vulva in females, and anus and scrotum in males.",
                            "codes": [
                                "ncit:C33301"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Pleural Effusion": {
                            "description": "Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.",
                            "codes": [
                                "ncit:C3331"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Prostate": {
                            "description": "The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.",
                            "codes": [
                                "ncit:C12410"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Retroperitoneum": {
                            "description": "The back of the abdomen where the kidneys lie and the great blood vessels run.",
                            "codes": [
                                "ncit:C12298"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Scalp": {
                            "description": "The skin which covers the top of the head and which is usually covered by hair.",
                            "codes": [
                                "ncit:C89807"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Shoulder": {
                            "description": "The region of the body between the neck and the upper arm.",
                            "codes": [
                                "ncit:C25203"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Soft Tissue": {
                            "description": "A general term comprising tissue that is not hardened or calcified; including muscle, fat, blood vessels, nerves, tendons, ligaments and fascia.",
                            "codes": [
                                "ncit:C12471"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thigh": {
                            "description": "A part of the lower limb, located between hip and knee.",
                            "codes": [
                                "ncit:C33763"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thorax": {
                            "description": "The division of the body lying between the neck and the abdomen.",
                            "codes": [
                                "ncit:C12799"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thyroid": {
                            "description": "An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.",
                            "codes": [
                                "ncit:C12400"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Trunk": {
                            "description": "The body excluding the head and neck and limbs.",
                            "codes": [
                                "ncit:C33816"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Upper Arm": {
                            "description": "The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.",
                            "codes": [
                                "ncit:C32141"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Uterus": {
                            "description": "A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.",
                            "codes": [
                                "ncit:C12405"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Vagina": {
                            "description": "The female genital canal, extending from the uterus to the vulva.",
                            "codes": [
                                "ncit:C12407"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Vulva": {
                            "description": "The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.",
                            "codes": [
                                "ncit:C12408"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other": {
                            "description": "Different than the one(s) previously specified or mentioned.",
                            "codes": [
                                "ncit:C17649"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "ncit:C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "ncit:C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "SITE_OTHER": {
                    "type": "String",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "Specify the \"Other\" SITE.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[TUMOR_SITE_OTHER] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[SITE_OTHER]"
                    ]
                },
                "TUMOR_SIZE": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The tumor size of the largest tumor.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "<=5 cm": {
                            "description": "The size of the tumor is less than or equal to 5 centimeters.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        ">5 cm": {
                            "description": "The size of the tumor is greater than 5 centimeters.",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "ncit:C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "ncit:C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "DIAMETER1": {
                    "type": "Decimal",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The longest diameter of the tumor.",
                    "codes": [
                        "ncit:C96684"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[LONGEST_DIAM_DIM1] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[DIAMETER1]"
                    ]
                },
                "DIAMETER1_UNIT": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The unit of measure symbol associated with a biospecimen or tissue fragment dimension.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "cm": {
                            "description": "A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.",
                            "codes": [
                                "ncit:C49668"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "DIAMETER2": {
                    "type": "Decimal",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The second longest diameter of the tumor.",
                    "codes": [
                        "ncit:C96684"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[LONGEST_DIAM_DIM2] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[DIAMETER2]"
                    ]
                },
                "DIAMETER2_UNIT": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The unit of measure symbol associated with a biospecimen or tissue fragment dimension.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "cm": {
                            "description": "A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.",
                            "codes": [
                                "ncit:C49668"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "DIAMETER3": {
                    "type": "Decimal",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The third longest diameter of the tumor.",
                    "codes": [
                        "ncit:C16809"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Tumor Assessment].[LONGEST_DIAM_DIM3] skos:exactMatch [rms_v2.0].[Disease Site Assessment].[DIAMETER3]"
                    ]
                },
                "DIAMETER3_UNIT": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The unit of measure symbol associated with a biospecimen or tissue fragment dimension.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ],
                    "permissible_values": {
                        "cm": {
                            "description": "A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.",
                            "codes": [
                                "ncit:C49668"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "INVASIVENESS": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "Tumor Invasiveness",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "T1 Stage Finding": {
                            "description": "A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.",
                            "codes": [
                                "ncit:C48720"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "T2 Stage Finding": {
                            "description": "A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.",
                            "codes": [
                                "ncit:C48724"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "TX Stage Finding": {
                            "description": "A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.",
                            "codes": [
                                "ncit:C48737"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "ncit:C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "ncit:C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "NODAL_PATHOLOGY": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Pathological Determination of Regional Lymph Node Involvement",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "N0 Stage Finding": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "N1 Stage FInding": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "NX Stage Finding": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "NODAL_CLINICAL": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Clinical Determination of Regional Lymph Node Involvemen",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "N0 Stage Finding": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "N1 Stage FInding": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "NX Stage Finding": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "PARAMENINGEAL_EXTENSION": {
                    "type": "Enum",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "Is there evidence of parameningeal extension of the tumor, indicating the spread of a tumor or pathological process beyond the primary site to involve the tissues adjacent to the meninges (the protective coverings of the brain and spinal cord)?",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Yes": {
                            "description": "The affirmative response to a question.",
                            "codes": [
                                "ncit:C49488"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "No": {
                            "description": "The non-affirmative response to a question.",
                            "codes": [
                                "ncit:C49487"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "ncit:C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "ncit:C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            }
        },
        "treatment": {
            "radiation_therapy": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "2 - contributors should prioritize inclusion if resources are available",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_RT_START": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age of subject (in days) at the start of radiation therapy.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "CLASSIFICATION": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The classification of a tumor based primarily on histopathological characteristics.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Radiation Therapy].[TUMOR_CLASSIFICATION] skos:exactMatch [rms_v2.0].[Radiation Therapy].[CLASSIFICATION]"
                    ],
                    "permissible_values": {
                        "Primary": {
                            "description": "A tumor at the original site of origin.",
                            "codes": [
                                "C8509"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Regional Nodes": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Metastatic": {
                            "description": "A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site. Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.",
                            "codes": [
                                "C3261"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "SITE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Radiation Therapy Site",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Radiation Therapy].[RT_SITE] skos:exactMatch [rms_v2.0].[Radiation Therapy].[SITE]"
                    ],
                    "permissible_values": {
                        "Pelvis": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Neck": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Retroperitoneum": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Perineum": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Ovary": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paratesticular": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Abdomen": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Kidney": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Shoulder": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Scalp": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Upper Arm": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Forearm": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Hand": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thigh": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Knee": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Leg": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Lower Leg": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Foot": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Brain": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paraspinal": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Vagina": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Eyelid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Orbit": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Cheek": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Hypopharynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Larynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Oral Cavity": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Oropharynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parotid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thyroid and Parathyroid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Middle Ear": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasal Cavity and Paranasal Sinuses": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasal Cavity": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paranasal Sinuses": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasopharynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Infratemporal Fossa/Pterygopalatine and Parapharyngeal Area": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Infratemporal Fossa/Pterygopalatine": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parapharyngeal Area": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bladder": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Prostate": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bladder/Prostate": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Cervix": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Uterus": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Vulva": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thorax": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Anal/Perianal": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Trunk": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone or Bone Marrow": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone Marrow": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Distant Lymph Nodes": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Pleural Effusion": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Soft Tissue": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Liver/Biliary Tract": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Lung": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "ENERGY_TYPE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Protons": {
                            "description": "A type of external beam radiation therapy using a beam of protons. It has the advantage of precisely localizing the radiation dose on the targeted tissue and avoiding damage to the healthy surrounding tissues.",
                            "codes": [
                                "C66897"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Photon": {
                            "description": "A single unit of electromagnetic radiation, generally considered to be a discrete particle having no mass or charge.",
                            "codes": [
                                "C88112"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Brachytherapy": {
                            "description": "A type of radiation therapy in which radioactive material is placed inside the body, into a tumor or body cavity.",
                            "codes": [
                                "C15195"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Electrons": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "DOSE": {
                    "type": "Integer",
                    "tier": "",
                    "description": "The total radiation dose administered.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Radiation Therapy].[RT_DOSE] skos:exactMatch [rms_v2.0].[Radiation Therapy].[DOSE]"
                    ]
                },
                "DOSE_UNIT": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A unit of measurement of the dose of radiation received or absorbed.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Radiation Therapy].[RT_UNIT] skos:exactMatch [rms_v2.0].[Radiation Therapy].[DOSE_UNIT]"
                    ],
                    "permissible_values": {
                        "Gy": {
                            "description": "A SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.",
                            "codes": [
                                "C18063"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            },
            "biopsy_and_surgical_procedures": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_PROCEDURE": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age of subject (in days) at procedure.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "TIME_PERIOD_SUBMITTER_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "This is the SUBMITTER_ID of the time period (defined in the \"Time Period\" table) during which this observation takes place.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "CLASSIFICATION": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The classification of a tumor based primarily on histopathological characteristics.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Biopsy/Surgical Procedures].[TUMOR_CLASSIFICATION] skos:exactMatch [rms_v2.0].[Biopsy And Surgical Procedures].[CLASSIFICATION]"
                    ],
                    "permissible_values": {
                        "Primary": {
                            "description": "A tumor at the original site of origin.",
                            "codes": [
                                "C8509"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Regional": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [
                                "Changed from \"Regional Nodes\" to \"Regional\" BTF 20210801"
                            ],
                            "mappings": []
                        },
                        "Metastatic": {
                            "description": "A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site. Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology.",
                            "codes": [
                                "C3261"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "SITE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The anatomical site on which surgery was performed.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [
                        "[rms_v1.0].[Biopsy/Surgical Procedures].[PROCEDURE_SITE] skos:exactMatch [rms_v2.0].[Biopsy And Surgical Procedures].[SITE]"
                    ],
                    "permissible_values": {
                        "Abdomen": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Anal/Perianal": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bladder": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bladder/Prostate": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone Marrow": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Bone or Bone Marrow": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Brain": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Cervix": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Cheek": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Distant Lymph Nodes": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Eyelid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Foot": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Forearm": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Hand": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Hypopharynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Infratemporal Fossa/Pterygopalatine": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Infratemporal Fossa/Pterygopalatine and Parapharyngeal Area": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Kidney": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Knee": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Larynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Leg": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Liver/Biliary Tract": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Lower Leg": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Lung": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Middle Ear": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasal Cavity": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasal Cavity and Paranasal Sinuses": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Nasopharynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Neck": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Oral Cavity": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Orbit": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Oropharynx": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Ovary": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paranasal Sinuses": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parapharyngeal Area": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paraspinal": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Paratesticular": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Parotid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Pelvis": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Perineum": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Pleural Effusion": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Prostate": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Retroperitoneum": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Scalp": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Shoulder": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Soft Tissue": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thigh": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thorax": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Thyroid and Parathyroid": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Trunk": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Upper Arm": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Uterus": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Vagina": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Vulva": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Other": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "PROCEDURE_TYPE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "A categorization of surgical procedures by type or purpose.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Surgery": {
                            "description": "A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.",
                            "codes": [
                                "C15329"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Biopsy": {
                            "description": "The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.",
                            "codes": [
                                "C15189"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "MARGINS": {
                    "type": "Enum",
                    "tier": "",
                    "description": "One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Incomplete Resection": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "R0 - Complete Resection, Negative": {
                            "description": "No detectable presence of residual tumor after treatment",
                            "codes": [
                                "C139578"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "R1 - Complete Resection, Positive": {
                            "description": "Presence of microscopic residual tumor after treatment.",
                            "codes": [
                                "C139579"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "R2 - Gross Residual Disease": {
                            "description": "Presence of macroscopic residual tumor after treatment.",
                            "codes": [
                                "C139580"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Gross Total Resection, Unknown Margins": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Unknown": {
                            "description": "Reported as unknown by the data contributor.",
                            "codes": [
                                "C17998"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Reported": {
                            "description": "Not provided or available.",
                            "codes": [
                                "C43234"
                            ],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            }
        },
        "response": {
            "subject_response": {
                "HONEST_BROKER_SUBJECT_ID": {
                    "type": "String",
                    "tier": "",
                    "description": "The identifier assigned to the subject by the honest broker. An individual, organization or system acting for, or on behalf of, a covered entity to collect and provide health information to research investigators in such a manner whereby it would not be reasonably possible for the investigators or others to identify the corresponding patients-subjects directly or indirectly. The honest broker cannot be one of the investigators. The information provided to the investigators by the honest broker may incorporate linkage codes to permit information collation and/or subsequent inquiries (i.e., a \"re-identification code\"), however the information linking this re- identification code to the patient's identity must be retained by the honest broker and subsequent inquiries are conducted through the honest broker.",
                    "codes": [
                        "ncit:C168949"
                    ],
                    "implementation_notes": [],
                    "mappings": [
                        "New VD"
                    ]
                },
                "AGE_AT_RESPONSE": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age of subject (in days) when the response assessment was made.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": []
                },
                "TX_PRIOR_RESPONSE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "Treatment Type Prior to Response Assessment",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Chemotherapy": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Chemoradiotherapy": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                },
                "RESPONSE": {
                    "type": "Enum",
                    "tier": "",
                    "description": "The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.",
                    "codes": [],
                    "implementation_notes": [],
                    "mappings": [],
                    "permissible_values": {
                        "Partial Response": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Stable Disease": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Progressive Disease": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Complete Response": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        },
                        "Not Evaluable": {
                            "description": "",
                            "codes": [],
                            "implementation_notes": [],
                            "mappings": []
                        }
                    }
                }
            }
        },
        "events": {
            "subsequent_malignant_neoplasm": {
                "AGE_AT_SMN": {
                    "type": "Integer",
                    "tier": "",
                    "description": "Age in Days at Subsequent Malignant Neoplasm",
                    "codes": [
                        "C168860"
                    ],
                    "implementation_notes": [],
                    "mappings": []
                }
            }
        }
    }
}